CirTran : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______________ to _______________

Commission File No. 000-49654

CirTran Corporation

(Exact name of registrant as specified in its charter)

Nevada		68-0121636
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

6360 S Pecos Road, Suite 8, Las Vegas, NV89120

(Address of principal executive offices and zip code)

[phone]

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		None		None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

	Large accelerated filer ☐	Accelerated filer ☐
	Non-accelerated filer☒	Smaller reporting company ☒
	Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. As of August 8, 2022, there were 4,945,417shares of common stock, $0.001 par value, outstanding.

TABLE OF CONTENTS

Item		Page
	Part I-Financial Information
1	Financial Statements (Unaudited)	3
	Consolidated Balance Sheets as of June 30, 2022 (unaudited) and December 31, 2021	3
	Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)	4
	Condensed Consolidated Statements of Stockholders' Deficit for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022 and 2021 (unaudited)	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
2	Management's Discussion and Analysis of Financial Condition and Results of Operations	16
3	Quantitative and Qualitative Disclosures about Market Risk	18
4	Controls and Procedures	18
	Part II-Other Information
6	Exhibits	19
	Signatures	20

2

PART I-FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CIRTRAN CORPORATION

CONSOLIDATED BALANCE SHEETS

		June 30, 2022			December 31, 2021
		(Unaudited)			(Audited)
ASSETS
Current assets:
Cash		$	6,846			$	5,472
Inventory			739,709				537,961
Deposits on inventory			40,410				11,639
Deposits on inventory - related party			245,007				87,042
Accounts receivable			153,621				212,244
Other current assets			286,166				267,820
Total current assets			1,471,759				1,122,178
Investment in securities at cost			300,000				300,000
Right-of-use asset			7,697				22,291
Property and equipment, net of accumulated depreciation			17,025				18,899
Total assets		$	1,796,481			$	1,463,368
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable		$	2,113,664			$	1,923,968
Lease liability, current			7,697				22,291
Related-party payable			13,740				13,740
Short-term advances payable			58,366				58,366
Short-term advances payable - related parties			21,882				21,882
Accrued liabilities			1,684,375				1,338,349
Accrued payroll and compensation expense			4,626,777				4,441,398
Accrued interest, current portion			5,094,422				4,880,219
Convertible debenture, current portion, net of discounts			264,284				264,284
Note payable, current portion			90,000				90,000
Note payable to stockholders			182,129				313,274
Derivative liability			972,746				938,794
Liabilities from discontinued operations			25,265,238				25,189,136
Total current liabilities:			40,395,320				39,495,701
Note payable, net of current portion			656,000				656,000
Convertible debenture, net of current portion, net of discount			1,921,533				1,876,621
Total liabilities			42,972,853				42,028,322
Commitments and contingencies			-				-
Stockholders' deficit:
Common stock, par value $0.001; 100,000,000shares authorized; 4,945,417shares issued and outstanding			4,945				4,945
Additional paid-in capital			37,233,561				37,233,561
Accumulated deficit			(78,414,878	)			(77,803,460	)
Total stockholders' deficit			(41,176,372	)			(40,564,954	)
Total liabilities and stockholders' deficit		$	1,796,481			$	1,463,368

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

		Three Months Ended June 30,			Six Months Ended June 30,
		2022			2021			2022			2021
Net sales		$	526,921			$	700,656			$	1,218,689			$	1,320,055
Cost of sales			178,474				262,411				410,853				464,059
Gross profit			348,447				438,245				807,836				855,996
Operating expenses
Employee costs			134,494				135,077				267,000				268,965
Selling, general and administrative expenses			317,594				359,297				693,771				638,595
Total operating expenses			452,088				494,374				960,771				907,560
Loss from operations			(103,641	)			(56,129	)			(152,935	)			(51,564	)
Other income (expense)
Interest expense			(175,081	)			(168,726	)			(348,432	)			(335,214	)
Gain (loss) on derivative valuation			2,104				13,131				(33,949	)			(114,660	)
Total other expense			(172,977	)			(155,595	)			(382,381	)			(449,874	)
Net loss from continuing operations			(276,618	)			(211,724	)			(535,316	)			(501,438	)
Loss from discontinued operations			(38,297	)			(38,261	)			(76,102	)			(76,102	)
Net loss		$	(314,915	)		$	(249,985	)		$	(611,418	)		$	(577,540	)
Net loss from continuing operations per common share, basic and diluted		$	(0.04	)		$	(0.04	)		$	(0.10	)		$	(0.10	)
Net loss from discontinued operations per common share, basic and diluted		$	(0.01	)		$	(0.01	)		$	(0.02	)		$	(0.02	)
Net loss per common share, basic and diluted		$	(0.05	)		$	(0.05	)		$	(0.12	)		$	(0.12	)
Basic and diluted weighted average common shares outstanding			4,945,417				4,945,417				4,945,417				4,928,584

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2022 AND 2021

(Unaudited)

		Common Stock			Additional Paid-in			Accumulated			Total Stockholders'
		Shares			Amount			Capital			Deficit			Deficit
Balance, December 31, 2021			4,945,417			$	4,945			$	37,233,561			$	(77,803,460	)		$	(40,564,954	)
Net loss			-				-				-				(296,503	)			(296,503	)
Balance, March 31, 2022			4,945,417				4,945				37,233,561				(78,099,963	)			(40,861,457	)
Net loss			-				-				-				(314,915	)			(314,915	)
Balance, June 30, 2022			4,945,417			$	4,945			$	37,233,561			$	(78,414,878	)		$	(41,176,372	)

		Common Stock			Additional Paid-in			Accumulated			Total Stockholders'
		Shares			Amount			Capital			Deficit			Deficit
Balance, December 31, 2020			4,720,417			$	4,720			$	37,226,851			$	(77,929,672	)		$	(40,698,101	)
Common stock issued for conversion of accrued interest			225,000				225				6,525				-				6,750
Net loss			-				-				-				(327,555	)			(327,555	)
Balance, March 31, 2021			4,945,417				4,945				37,233,376				(78,257,227	)			(41,018,906	)
Net loss			-				-				-				(249,985	)			(249,985	)
Balance, June 30, 2021			4,945,417			$	4,945			$	37,233,376			$	(78,507,212	)		$	(41,268,891	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

CIRTRAN CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

		For the Six Months Ended June 30,
		2022			2021
Cash flows from operating activities
Net loss		$	(611,418	)		$	(577,540	)
Adjustments to reconcile net income to net cash (used) provided by operating activities:
Loss from discontinued operations			76,102				76,102
Depreciation expense			1,874				1,953
Loss on derivative valuation			33,949				114,660
Debt discount amortization			44,912				22,608
Amortization of right-of-use asset to rent expense			14,594				14,146
Expenses paid on our behalf by a related party			-				(199,909	)
Changes in operating assets and liabilities:
Inventory			(201,748	)			(272,204	)
Deposits on inventory			(28,771	)			42,261
Deposits on inventory - related party			(157,965	)			237,512
Accounts receivable			58,623				(126,429	)
Other current assets			(18,346	)			(191,003	)
Accounts payable			189,696				219,570
Accrued liabilities			404,753				87,890
Payments for lease liability			(14,594	)			(14,146	)
Accrued payroll and compensation			96,062				192,427
Accrued interest			214,203				290,895
Net cash provided (used) by operating activities			101,926				(81,207	)
Cash flows from investing activities:
Purchase of equipment			-				(1,624	)
Net cash used in investing activities			-				(1,624	)
Cash flows from financing activities:
Proceeds from convertible loans payable			-				21,337
Proceeds from related-party loans			6,930				-
Repayments of related-party loans			(107,482	)			(30,000	)
Net cash used by financing activities			(100,552	)			(8,663	)
Net change in cash			1,374				(91,494	)
Cash, beginning of period			5,472				108,147
Cash, end of period		$	6,846			$	16,653
Supplemental disclosure of cash flow information:
Cash paid for interest		$	-			$	-
Cash paid for income taxes		$	-			$	-
Supplemental disclosure of noncash investing activities:
Common stock issued for conversion of accrued interest		$	-			$	6,750

The accompanying notes are an integral part of these unaudited condensed financial statements.

6

CIRTRAN CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022

NOTE 1 - ORGANIZATION AND NATURE OF OPERATIONS

In 1987, CirTran Corporation was incorporated in Nevada under the name Vermillion Ventures, Inc., for the purpose of acquiring other operating corporate entities. We were largely inactive until July 1, 2000, when our wholly owned subsidiary, CirTran Corporation (Utah), acquired substantially all the assets and certain liabilities of Circuit Technology, Inc., founded by our president, Iehab Hawatmeh.

We, together with our majority-owned subsidiaries, manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name. Since entering our 2019 five-year manufacturing and distribution agreement with an unrelated party, our efforts have been devoted to phase one of our development of all HUSTLER®-branded products, which led us to generating revenue during 2020 for the first time in several years.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Our unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), and pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). These financial statements and the notes attached hereto should be read in conjunction with the financial statements and notes included in our Form 10-K for the fiscal year ended December 31, 2021. In the opinion of our management, all adjustments, including normal recurring adjustments necessary to present fairly our financial position, as of June 30, 2022, and the results of our operations and cash flows for the six months then ended have been included. The results of operations for the interim period are not necessarily indicative of the results for the full year ending December 31, 2022.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the estimated useful lives of property and equipment. Actual results could differ from those estimates.

Principles of Consolidation

The consolidated financial statements include the accounts of the company and our wholly owned subsidiaries: CirTran Products Corp., LBC Products, Inc., and CirTran Asia, Inc. All intercompany accounts and transactions have been eliminated in consolidation

Revenue Recognition

We follow Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers, for revenue recognition. Adoption of ASC 606 did not have a significant impact on our financial statements. We generate revenue by providing product design services and through the sales of tangible product. We recognize revenue upon transfer of control of promised products or services to customers in an amount that reflects the consideration expected to be received in exchange for those products or services. We determine the transaction price associated with each deliverable based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Revenue is recognized net of allowances for returns and any taxes collected from customers, which are subsequently remitted to governmental authorities.

7

During the six months ended June 30, 2022 and 2021, we recognized revenue of $227,404and $30,000, respectively, and $97,106and $15,000, during the three months ended June 30, 2022 and 2021, respectively, related to the performance obligations under product development service agreements with customers. These contracts are long term in nature and revenue is recognized at certain milestone intervals upon our delivery and customer acceptance of work product related to those milestones: namely, product design, packaging, branding display, and prototypes. There were no costs to obtain the contracts identified, and therefore, no asset has been recorded for customer acquisition costs.

Additionally, we recognized revenue of $991,285and $1,290,055during the six months ended June 30, 2022 and 2021, respectively, and $429,816and $55,656, during the three months ended June 30, 2022 and 2021, respectively, related to the delivery of product to our customers. Each delivery is based on the unique contract with the customer, which is a stand-alone contract that we retain the right to accept or reject. Upon acceptance, we oblige delivery of such product to the customer at an agreed-upon place, time, and price. We recognize revenue under the unique contract upon fulfilment of our performance obligations therein, typically limited to the delivery of product.

Leases

In February 2016, the FASB issued Accounting Standard Update ("ASU") 2016-02, Leases (Topic 842), which superseded guidance in ASC 840, Leases, which we adopted for the year ended December 31, 2019, under the modified retrospective transition approach by applying the new standard to all leases existing at the date of initial application. We account for short-term leases, those lasting fewer than 12 months, using the practical expedient as outlined in the guidance, which does not include recording such leases on the balance sheet.

The adoption of the standard resulted in recording right-of-use ("ROU") assets and operating lease liabilities of $22,291as of December 31, 2021. Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at commencement date. As the lease does not provide an implicit rate, we use our incremental borrowing rate based on information available at the commencement date in determining the present value of future payments. The operating lease ROU asset also includes any lease payments made and excludes lease incentives and initial direct costs incurred. Lease terms may include options to extend or terminate the lease when it is reasonably certain we will exercise that option. Although considered, we determined it was appropriate to exclude future renewal terms from the capitalization of our operating lease.

We have one lease in effect requiring minimum monthly payments of $2,500through October 2022. We have determined the appropriate discount rate to be 5% based on our other borrowings secured by assets. A summary of future payments due under the terms of the lease as of June 30, 2022, is as follows:

Total future payments		$	8,000
Implied interest			(303	)
Operating lease liability as of June 30, 2022		$	7,697

Investment in Securities

Our cost-method investment consists of an investment in a private digital multi-media technology company that totalled $300,000at June 30, 2022, and December 31, 2021. Because we owned less than 20% of that company's stock as of each date, and no significant influence or control exists, the investment is accounted for using the cost method. We evaluated the investment for impairment and determined there was none during the periods presented.

Inventories

Inventories are stated at the lower of average cost or net realizable value. Cost on manufactured inventories includes labor, material, and overhead. Overhead cost is based on indirect costs allocated to cost of sales, work-in-process inventory, and finished goods inventory. Indirect overhead costs have been charged to cost of sales or capitalized as inventory, based on management's estimate of the benefit of indirect manufacturing costs to the manufacturing process.

8

When there is evidence that the inventory's value is less than original cost, the inventory is reduced to market value. We determine market value on current resale amounts and whether technological obsolescence exists. We will seek agreements with manufacturing customers that require them to purchase their inventory items in the event they cancel their business with us.

From time to time, we will place deposits on inventory to be delivered in the future. These deposits are carried as a separate balance sheet component and totalled $40,410(non-related-party) and $245,007(related-party) as of June 30, 2022, and $11,639(non-related-party) and $87,042(related-party) as of December 31, 2021.

Inventory balances consisted of the following:

		June 30, 2022			December 31, 2021
Finished goods		$	723,296			$	501,929
Raw materials			16,413				36,032
Total		$	739,709			$	537,961

Fair Value of Financial Instruments

ASC 820-10-15, Fair Value Measurement-Overall-Scope and Scope Exceptions, defines fair value, thereby eliminating inconsistencies in guidance found in various prior accounting pronouncements, and increases disclosures surrounding fair value calculations. ASC 820-10-15 establishes a three-tiered fair value hierarchy that prioritizes inputs to valuation techniques used in fair value calculations. The three levels of inputs are defined as follows:

Level 1-Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities.

Level 2-Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data.

Level 3-Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Accounts payable and related-party payables have fair values that approximate the carrying value due to the short-term nature of these instruments. Derivative liabilities are measured using level 3 inputs.

		Total Fair Value at June 30, 2022			Quoted prices in active markets (Level 1)			Significant other observable inputs (Level 2)			Significant unobservable inputs (Level 3)
Derivative liabilities		$	972,746			$	-			$	-			$	972,746

		Total Fair Value at December 31, 2021			Quoted prices in active markets (Level 1)			Significant other observable inputs (Level 2)			Significant unobservable inputs (Level 3)
Derivative liabilities		$	938,794			$	-			$	-			$	938,794

9

Loss per Share

Basic loss per share is calculated by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during each period. Diluted loss per share is similarly calculated, except that the weighted-average number of common shares outstanding would include common shares that may be issued subject to existing rights with dilutive potential when applicable. There were 79,146,472potentially issuable shares from the conversions of convertible debentures outstanding that were excluded in dilutive outstanding shares as of June 30, 2022, due to the anti-dilutive effect these would have on net loss per share. There were 141,554,300such shares issuable as of June 30, 2021. We do not currently have adequate authorized but unissued shares to satisfy our obligations should all instruments eligible to convert to common stock be exercised. We are not currently contemplating an increase in our authorized shares but may do so in the future.

Recently Issued Accounting Pronouncements

We have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on our financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

NOTE 3 - GOING CONCERN

The accompanying unaudited consolidated financial statements have been prepared in conformity with U.S. GAAP, which contemplate our continuation as a going concern. We had a working capital deficiency of $38,923,561as of June 30, 2022, and a net loss from continuing operations of $535,316for the six months ended June 30, 2022. As of June 30, 2022, we had an accumulated deficit of $78,414,878. These conditions raise substantial doubt about our ability to continue as a going concern.

Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our business plan and eventually attain profitable operations. The accompanying financial statements do not include any adjustments that may be necessary if we are unable to continue as a going concern.

In the coming year, our foreseeable cash requirements will relate to development of business operations and associated expenses. We may experience a cash shortfall and be required to raise additional capital.

Historically, we have mainly relied upon shareholder loans and advances to finance operations and growth. Management may raise additional capital by retaining net earnings, if any, or through future public or private offerings of our stock or loans from private investors, although we cannot assure that we will be able to obtain such financing. Our failure to do so could have a material and adverse effect upon our shareholders and us.

NOTE 4 - PROPERTY AND EQUIPMENT

We incur certain costs associated with the design and development of molds and dies for our contract-manufacturing segment. These costs are held as deposits on the balance sheet until the molds or dies are finished and ready for use. At that point, the costs are included as part of production equipment in property and equipment and are amortized over their useful lives. We hold title to all molds and dies used in the manufacture of products.

Property and equipment and estimated service lives consist of the following:

		June 30, 2022			December 31, 2021			Useful Life (years)
Furniture and office equipment		$	3,798			$	3,798			5-10
Vehicles			18,672				18,672			3-7
Total			22,470				22,470
Less: accumulated depreciation			(5,445	)			(3,571	)
Property and equipment, net		$	17,025			$	18,899

We recorded $1,874and $1,953of depreciation expense for the six months ended June 30, 2022 and 2021.

10

NOTE 5 - RELATED PARTY TRANSACTIONS

In 2007, we issued a 10% promissory note to a family member of our president in exchange for $300,000. The note was due on demand after May 2008.There were no repayments made during the periods presented. At June 30, 2022, and December 31, 2021, the principal amount owing on the note was $151,833and $151,833, respectively. No demand for payment has been made.

On March 31, 2008, we issued to this same family member, along with two other company shareholders, promissory notes totaling $315,000($105,000each). Under the terms of these three $105,000notes, we received total proceeds of $300,000and agreed to repay the amount received plus a 5% borrowing fee. The notes were due April 30, 2008, after which they were due on demand, with interest accruing at 12% per annum. We made no payments towards the outstanding notes during the periods presented. The principal balance owing on the notes as of June 30, 2022, and December 31, 2021, was $72,466and $72,466, respectively. No demand for payment has been made.

During the six months ended June 30, 2022, we made repayments to related parties of $107,482and had other noncash reductions of $166,747. There were $21,882and $21,882of short-term advances due to related parties as of June 30, 2022, and December 31, 2021, respectively. The advances are due on demand and included in current liabilities. No demand for payment has been made.

We have agreed to issue stock options to Iehab Hawatmeh, our president, as compensation for services provided as our chief executive officer. The terms of his employment agreement require us to grant options to purchase 6,000shares of our stock each year, with an exercise $0.10. Mr. Hawatmeh held outstanding options to purchase 24,000and 30,000shares of common stock as of June 30, 2022, and December 31, 2021, respectively. See Note 12-Stock Options.

As of June 30, 2022, and December 31, 2021, we owed our president a total of $433,379and $433,379, respectively, in unsecured advances. The advances and short-term bridge loans were approved by our board of directors under a 5% borrowing fee. The borrowing fees were waived by our president on these loans. These amounts are included in our liabilities from discontinued operations.

As of June 30, 2022, and December 31, 2021, we owed a total of $13,740and $13,740, respectively, to a related party through trade payables incurred in the normal course of business. These amounts are shown as a separate related-party payable on the balance sheet as of each reporting date.

During the six months ended June 30, 2022, we had a net increase in deposits with a related-party inventory supplier totaling $157,965. The related party is an entity controlled by our chief executive officer. All transactions were at a 2% markup over the related-party's cost paid for inventory in arm's-length transactions. Total inventory purchases from the related party were $548,606and $819,882during the six months ended June 30, 2022 and 2021, respectively.

NOTE 6 - OTHER ACCRUED LIABILITIES

Accrued tax liabilities consist of delinquent payroll taxes, interest, and penalties owed by us to the Internal Revenue Service ("IRS") and other tax entities.

Accrued liabilities consist of the following:

		June 30, 2022			December 31, 2021
Tax liabilities		$	586,041			$	545,221
Other			1,098,334				793,128
Total		$	1,684,375			$	1,338,349

Other accrued liabilities as of June 30 2022, and December 31, 2021, include a non-interest-bearing payable totaling $45,000and $45,000, respectively, that is due on demand and customer deposits totaling $1,097,696and $718,535, respectively.

11

Accrued payroll and compensation liabilities consist of the following:

		June 30, 2022			December 31, 2021
Director fees		$	135,000			$	135,000
Bonus expenses			126,858				121,858
Commissions			2,148				2,148
Consulting			525,322				575,322
Administrative payroll			3,837,449				3,607,070
Total		$	4,626,777			$	4,441,398

NOTE 7 - COMMITMENTS AND CONTINGENCIES

Litigation and Claims

Various vendors, service providers, and others have asserted legal claims in previous years. These creditors generally are not actively seeking collection of amounts due to them, and we have determined that the probability of realizing any loss on these claims is remote and will seek to compromise and settle at a deep discount any of such claims that are asserted for collection. These amounts are included in our current liabilities, except where we believe collection or enforcement of the judgments is barred by the applicable statute of limitations, in which case the liabilities have been eliminated. We have not accrued any liability for claims or judgments that we have determined to be barred by the applicable statute of limitations, which generally is eight years for judgments in Utah.

Playboy Enterprises, Inc.

Our affiliate, Play Beverages, LLC, filed suit against Playboy Enterprises, Inc., in Cook County, Illinois, Circuit Court in October 2012 asserting numerous claims, including breach of contract and tortious interference. Playboy responded with a counterclaim of breach of contract and trademark infringement. After proceedings in October 2016, the court awarded a judgment of $6.6million to Playboy against Play Beverages and CirTran Beverage Corp., our subsidiary. The court denied our motion for a new trial and awarded Playboy treble patent infringement damages and attorney's fees. We filed a notice of appeal in July 2017 and again in March 2018. Playboy has initiated collection efforts but has recovered no funds. In September 2018, the appellate court affirmed the judgment of the circuit court. We have accrued $17,205,599as of June 30, 2022, and December 31, 2021, related to this judgment, which is included in liabilities in discontinued operations.

Delinquent Payroll Taxes, Interest, and Penalties

In November 2004, the IRS accepted our amended offer in compromise (the "Offer") to settle delinquent payroll taxes, interest, and penalties, which required us to pay $500,000, remain current in our payment of taxes for five years, and forego claiming any net operating losses for the years 2001 through 2015 or until we paid taxes on future profits in an amount equal to the taxes of $1,455,767waived by the Offer. In June 2013, we entered into a partial installment agreement to pay $768,526in unpaid 2009 payroll taxes, which required us to pay the IRS 5% of cash deposits. The monthly payments were to continue until the account balances were paid in full or until the collection statute of limitation expired on October 6, 2020. We are currently in communication with the IRS regarding the statute of limitations on this settlement and appropriate next steps. Amounts of $517,684and $525,238were due as June 30, 2022, and December 31, 2021, respectively.

Employment Agreements

We engage Iehab Hawatmeh, our president and chief executive officer, through an employment agreement entered in August 2009 and amended in September 2017. In July 2017, Mr. Hawatmeh had resigned all positions with us to pursue other business activities, thereby effectively terminating the agreement. However, the amendment to his employment agreement in September 2017 reinstated Mr. Hawatmeh to his previous positions, with a salary in an amount to be determined. Among other things, the reinstated employment agreement: (a) grants options to purchase a minimum of 6,000shares of our stock each year, with an exercise price equal to the market price of our common stock as of the grant date, for the maximum term allowed under our stock option plan; (b) provides for health insurance coverage, cell phone, car allowance, life insurance, and director and officer liability insurance, as well as any other bonus approved by our board; and (c) includes additional incentive compensation as follows: (i) a quarterly bonus equal to 5% of our earnings before interest, taxes, depreciation, and amortization for the applicable quarter; (ii) bonuses equal to 1% of the net purchase price of any acquisitions we complete that are directly generated and arranged by Mr. Hawatmeh; and (iii) an annual bonus (payable quarterly) equal to 1% of our gross sales of all products, net of returns and allowances. On January 1, 2020, we resumed accruing wages for our chief executive officer. A total of $172,500was accrued during the six months ended June 30, 2022.

12

We also have an oral agreement with our other director that requires us to issue options to purchase 2,000shares of our common stock each year.

License Agreements

We have entered into agreements requiring us to pay certain royalties for the manufacture and distribution of licensed products. Fees are based on a percentage of sales and remitted quarterly and are included in cost of sales for financial reporting purposes.

NOTE 8 - NOTES PAYABLE

Notes payable consisted of the following:

		June 30, 2022			December 31, 2021
Note payable to former service provider for past due account payable (current)		$	90,000			$	90,000
Note payable for settlement of debt (long-term)			500,000				500,000
Small Business Administration loan			156,000				156,000
Total		$	746,000			$	746,000

There was $287,115and $252,665of accrued interest due on these notes as of June 30, 2022, and December 31, 2021, respectively.

NOTE 9 - CONVERTIBLE DEBENTURES

Convertible debentures consisted of the following:

		June 30, 2022			December 31, 2021
Convertible debenture,5% stated interest rate, secured by all our assets, due on December 30, 2022		$	200,000			$	200,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on December 8, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on December 30, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on December 8, 2022			25,000				25,000
Convertible debenture, 5% stated interest rate, secured by all our assets, due on April 30, 2027			2,390,528				2,390,528
Subtotal		$	2,665,528			$	2,665,528
Less: discounts			(479,711	)			(524,623	)
Total		$	2,185,817			$	2,140,905
Less: current portion			(264,284	)			(264,284	)
Long-term portion		$	1,921,533			$	1,876,621

The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100or the lowest bid price for the 20trading days prior to conversion. During the year ended December 31, 2021, the convertible debenture holder converted $6,750of accrued but unpaid interest into 225,000shares of our common stock.

As of June 30, 2022, and December 31, 2021, we had accrued interest on the convertible debentures totaling $1,721,128and $1,655,037, respectively.

13

NOTE 10 - DERIVATIVE LIABILITIES

As discussed in Note 9-Convertible Debentures, we have entered into five separate agreements to borrow a total of $2,665,528with the outstanding principal and interest being convertible at the holder's option into common stock of the company at the lesser of $100(notes one through four) or $0.10 (note five) or the lowest closing bid price in the prior 20 trading days. Embedded derivatives are valued separately from the host instrument and are recognized as derivative liabilities in our balance sheet. We measure these instruments at their estimated fair value and recognize changes in their estimated fair value in results of operations during the period of change. We have estimated the fair value of these embedded derivatives for convertible debentures using a Monte Carlo simulation as of June 30, 2022, using the following assumptions:

Volatility		106.4% - 109.8	%
Risk-free rates		2.36% - 2.66	%
Stock price	$	0.051
Remaining life		0.25- 4.83years

The fair values of the derivative instruments are measured each quarter, which resulted in a loss of $33,949and $114,660during the six months ended June 30, 2022 and 2021, respectively. As of June 30, 2022, and December 31, 2021, the fair market value of the derivatives aggregated $972,746and $938,794, respectively.

NOTE 11 -COMMON STOCK TRANSACTIONS

We are authorized to issue up to 100,000,000shares of $0.001par value common stock.

During the year ended December 31, 2021, we issued a total of 225,000shares of common stock for the conversion of $6,750of accrued interest.

NOTE 12 - STOCK OPTIONS

Stock Incentive Plans

During the six months ended June 30, 2022, and the year ended December 31, 2021, we granted to employees 0and 8,000options to purchase shares of common stock, respectively.

The 8,000options granted during the year ended December 31, 2021, were valued using the following assumptions: estimated five-year term, estimated volatility of 91%, and a risk-free rate of 1.61%.

As of June 30, 2022, and December 31, 2021, we hadnounrecognized compensation related to outstanding options that have not yet vested at year-end that would be recognized in subsequent periods.

As of June 30, 2022, there were 32,000options issued and vested with a weighted average exercise price of $0.06and a weighted average remaining life of 2.66years. Outstanding options as of June 30, 2022, consisted of:

Exercise Price			Count			Average Exercise			Remaining Life			Exercisable
$					0.01				16,000				0.01				3.60				16,000
$					0.10				16,000				0.10				1.73				16,000
Total								32,000				0.06				2.66				32,000

14

NOTE 13-DISCONTINUED OPERATIONS

At October 21, 2016, we exited the beverage licensing and distribution business. The assets and liabilities associated with this business are displayed as assets and liabilities from discontinued operations as of June 30, 2022, and December 31, 2021. Additionally, the revenues and costs associated with this business are displayed as losses from discontinued operations for the six months ended June 30, 2022 and 2021.

Total assets and liabilities included in discontinued operations were as follows:

		June 30, 2022			December 31, 2021
Assets from Discontinued Operations:
Cash		$	-			$	-
Total assets from discontinued operations		$	-			$	-
Liabilities from Discontinued Operations:
Accounts payable		$	18,338,848			$	18,338,848
Accrued liabilities			589,380				589,380
Accrued interest			1,405,794				1,329,692
Accrued payroll and compensation expense			131,108				131,108
Current maturities of long-term debt			239,085				239,085
Related-party payable			1,776,250				1,776,250
Short-term advances payable			2,784,773				2,784,773
Total liabilities from discontinued operations		$	25,265,238			$	25,189,136

Net loss from discontinued operations for the six months ended June 30, 2022 and 2021, were comprised of the following components:

		Six Months ended June 30,
		2022			2021
Other expense:
Interest expense			(76,102	)			(76,102	)
Net loss from discontinued operations		$	(76,102	)		$	(76,102	)

NOTE 14 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10), management has performed an evaluation of subsequent events through the date that the financial statements were issued and has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.

15

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our condensed consolidated unaudited financial statements and notes to our unaudited financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors discussed elsewhere in this report.

Overview

Based on our diversified expertise in manufacturing, marketing, distribution, and technology services in a wide variety of consumer products, including tobacco products, medical devices, and beverages, around the world, we have an innovative and consumer-focused approach to brand portfolio management, resting on a strong understanding of consumers domestically, and we have established a footprint in more than 50 key, international markets.

During 2021 and into 2022, we continued under our 2019 five-year manufacturing and distribution agreement with an unrelated party to manufacture, distribute, and sell condoms, electronic tobacco products, cigars, energy drinks, water beverages, and related merchandise, all using the HUSTLER® brand name.

Results of Operations for the Three Months Ended June 30, 2022, Compared to the Three Months Ended June 30, 2021

Sales and Cost of Sales

During the three months ended June 30, 2022 and 2021, we had net sales of $526,921 and $700,656, respectively, a decrease of $173,735 or 24.8%. We had cost of sales of $178,474 and $262,411, respectively, for gross profit of $348,447 and $438,245, respectively. Revenues are derived from the design, manufacture, and delivery of certain licensed products in accordance with our GloBrands-HUSTLER® distribution agreement.

Operating Expenses

During the three months ended June 30, 2022 and 2021, employee costs were $134,494 and $135,077, respectively, a decrease of only $583 or 0.4%. Selling, general, and administrative expenses were $317,594 and $359,297, respectively, a decrease of $41,703 or 115.8%. The decrease in operating expenses period over period was the result of selling certain tobacco products in states with lower or no excise tax.

Other Expense

Other expenses during the three months ended June 30, 2022 and 2021, consisted of $175,081 and $168,726 of interest expense and a gain of $2,104 and $13,131 on derivative valuation, respectively. The increase in other expenses period over period is the result of a decrease to our loss on derivative valuation combined with increased interest expense.

Results of Operations for the Six Months Ended June 30, 2022, Compared to the Six Months Ended June 30, 2021

Sales and Cost of Sales

During the six months ended June 30, 2022 and 2021, we had net sales of $1,218,689 and $1,320,055, respectively, a decrease of $101,366 or 7.7%. We had cost of sales of $410,853 and $464,059, respectively, for gross profit of $807,836 and $855,996, respectively. Revenues are derived from the design, manufacture, and delivery of certain licensed products in accordance with our GloBrands-HUSTLER® distribution agreement.

16

Operating Expenses

During the six months ended June 30, 2022 and 2021, employee costs were $267,000 and $268,965, respectively, a decrease of only $1,965 or 0.7%. Selling, general, and administrative expenses were $696,771 and $638,595, respectively, an increase of $55,176 or 8.6%. The decrease in operating expenses period over period is the result of substantially increased activities attributable to the development of products under the HUSTLER® brand name and selling certain tobacco products in states with lower or no excise tax in the first quarter.

Other Expense

Other expenses during the six months ended June 30, 2022 and 2021, consisted of $348,432 and $335,214 of interest expense and a loss of $33,949 and $114,660 on derivative valuation, respectively. The decrease in other expenses period over period is the result of a decrease to our loss on derivative valuation combined with increased interest expense.

Liquidity and Capital Resources

We have had a history of losses from operations, as our expenses have been greater than our revenue. Our accumulated deficit was approximately $78.4 million at June 30, 2022. As of June 30, 2022, we had current assets of $1,471,759 and current liabilities of approximately $40 million, resulting in a working capital deficit of approximately $38.9 million at June 30, 2022.

Operating Activities

During the six months ended June 30, 2022, operations generated $101,926 of net cash, comprised of a loss from continuing operations of $535,316, noncash items totaling $95,332 consisting primarily of losses recognized from the changes in fair values of derivative liabilities and debt discount amortization, and changes in working capital totaling $541,910. During the six months ended June 30, 2021, operations used $81,207 of net cash, comprised of a net loss from continuing operations of $501,438, noncash items totaling $153,367 consisting of losses recognized from the changes in fair values of derivative liabilities and expense paid by related parties on our behalf, and changes in working capital totaling $466,733.

Financing Activities

During the six months ended June 30, 2022, financing activities used $100,552 of cash, compared to using $8,663 of cash during the six months ended June 30, 2021. Cash used in financing consisted of repayments of related-party loans.

Our Capital Resources and Anticipated Requirements

Our monthly operating costs are approximately $35,000 per month, excluding approximately $50,000 of accruing interest expense and capital expenditures. We continue to focus on generating revenue and reducing our monthly business expenses through cost reductions and operational streamlining. We have only recently begun to generate enough cash to sustain our day-to-day operations, and we expect to access external capital resources in the future to fund any new projects we may undertake. We cannot assure that we will be successful in obtaining such capital.

If we seek infusions of capital from investors, it is unlikely that we will be able to obtain additional debt financing. If we did incur additional debt, we would be required to devote additional cash flow to servicing the debt and securing the debt with assets.

Our issuance of additional shares for equity or for conversion of debt could dilute the value of our common stock and existing stockholders' positions.

17

Convertible Debentures and Note Payable

We currently have an outstanding amended, restated, and consolidated secured convertible debenture with Tekfine, LLC, an unrelated entity, with a maturity date of April 30, 2027, to the extent not previously converted. The amended debenture had a total outstanding principal balance of $2.4 million, with accrued interest of $1.7 million as of June 30, 2022. We also have four additional convertible debentures with Tekfine with maturity dates ranging from December 8, 2022, until December 30, 2022, totaling $275,000, unless earlier converted. The convertible debentures and accrued interest are convertible into shares of our common stock at the lower of $100 or $0.10 (depending on the instrument) or the lowest bid price for the 20 trading days prior to conversion.

During the six months ended June 30, 2022, we made repayments to related parties of $35,000 and had other noncash reductions of $166,747. There were $21,882 and $21,882 of short-term advances due to related parties as of June 30, 2022, and December 31, 2021, respectively. The advances are due on demand and included in current liabilities. No demand for payment has been made.

Going Concern

These interim unaudited financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing will be obtained as required and that our assets will be realized and liabilities settled in the ordinary course of business. Accordingly, the interim unaudited financial statements do not include any adjustments related to the recoverability of assets and classification of assets and liabilities that might be necessary should we not be unable to continue as a going concern.

Critical Accounting Policies

We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. Refer to Note 2 - Summary of Significant Accounting Policies for discussion.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide the information required by this item.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of June 30, 2022, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive and financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of June 30, 2022, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange Commission and that such information is accumulated and communicated to management, including our chief executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended June 30, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

18

PART II-OTHER INFORMATION

ITEM 6. EXHIBITS

The following exhibits are filed as a part of this report:

Exhibit Number*		Title of Document		Location
Item 31		Rule 13a-14(a)/15d-14(a) Certifications
31.01		Certification of Principal Executive and Principal Financial Officer Pursuant to Rule 13a-14		This filing.
Item 32		Section 1350 Certifications
32.01		Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002		This filing.
Item 101		Interactive Data File
101.INS		Inline XBRL Instance Document		This filing.
101.SCH		Inline XBRL Taxonomy Extension Schema		This filing.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase		This filing.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase		This filing.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase		This filing.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase		This filing.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

*

All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the document's sequence.

**

The XBRL related information in Exhibit 101 will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and will not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as is expressly set forth by specific reference in such filing or document.

19

SIGNATURE PAGE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	CIRTRAN CORPORATION
Dated: August 19, 2022	By:	/s/ Iehab Hawatmeh
		Iehab Hawatmeh, President
		Principal Executive and Financial Officer

20